SARS-CoV-2 infection correlates with male benign prostatic hyperplasia deterioration.

Alex Qinyang LiuPeter Ka-Fung ChiuSamuel Chi-Hang YeeChi-Fai NgJeremy Yuen-Chun Teoh

Published in: Journal of internal medicine (2023)

SARS-CoV-2 infection is associated with increased incidence of urinary retention, haematuria, UTI and the addition of combination therapy in the short term, regardless of COVID-19 severity. This is the largest study demonstrating the detrimental urological effects of SARS-CoV-2 infection.

Keyphrases

combination therapy
respiratory syndrome coronavirus
benign prostatic hyperplasia
lower urinary tract symptoms
sars cov
coronavirus disease
risk factors
urinary tract